metformin has been researched along with cholecalciferol in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 12 (60.00) | 24.3611 |
2020's | 7 (35.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Figenschau, Y; Jorde, R | 1 |
Darzynkiewicz, Z; Halicka, HD; Hsieh, TC; Lee, YS; Li, J; Wu, JM; Zhao, H | 1 |
Al-Daghri, NM; Al-Othman, A; Al-Saleh, Y; Alkharfy, KM; Alokail, MS; Chrousos, GP; Kumar, S; Moharram, O; Sabico, SB | 1 |
Baldissareli, J; Calgaroto, NS; Carvalho, FB; da Costa, P; de Oliveira, LS; Hussein, FA; Morsch, VM; Pereira, LB; Ribeiro, DA; Rubin, MA; Schetinger, MR; Schmatz, R; Signor, C; Thomé, GR | 1 |
Berger, NA; Dong, SH; Gao, JM; Guo, LS; Li, CY; Li, HX; Li, L; Li, W; Liu, X; Ma, L; Wang, QL; Wu, YJ | 1 |
Baldissarelli, J; Calgaroto, NS; Cardoso, AM; da Costa, P; Dalenogare, D; Morsch, VM; Pelinson, LP; Pereira, LB; Schetinger, MR; Vieira, JM | 1 |
Fu, M; Gao, JM; Li, HX; Liang, JQ; Wu, YJ; Xi, JM | 1 |
Chen, J; Gao, JM; Gao, MT; Guo, LS; Li, CY; Li, HX; Liang, JQ; Wang, QL; Wu, YJ; Zhang, SY | 2 |
Guo, M; Ji, X; Li, R; Liang, W; Mao, Y; Qin, X; Sheng, X; Song, Y; Wang, F; Xiao, J; Zhang, X | 1 |
Ahmed, AS; Al-Najjar, AH; El-Gharabawy, RM | 1 |
Byun, S; Lee, E; Lee, KW | 1 |
Abenavoli, L; Aludwan, M; Fagoonee, S; Kobyliak, N; Komisarenko, I; Kyriienko, D; Pellicano, R | 1 |
Abdel-Aal, M; Abdel-Ghany, RH; Alsemeh, AE; Ghareib, SA; Wahba, NS | 1 |
Abdel-Aal, M; Abdel-Ghany, RH; Alsemeh, AE; Ghareib, SA; Sabry, D; Wahba, NS | 1 |
Al-Dhabi, NA; Arasu, MV; Arockiaraj, J; C, M; Chatterjee, S; Choi, KC; Karuppiah, K; Natarajan, S; Raj, V; Ramanujam, GM; Ramasamy, M | 1 |
Assmann, CE; Baldissarelli, J; Bissacotti, BF; Bottari, NB; Castro, MFV; Miron, VV; Morsch, VMM; Mostardeiro, VB; Nauderer, JN; Palma, TV; Pereira, ADS; Schetinger, MRC; Stefanello, N | 1 |
Dovban, O; Kharchenko, Y; Kovalchuk, Y; Lievykh, A; Shevtsova, A; Tkachenko, V; Ushakova, G; Zhyliuk, V | 1 |
Chen, H; Li, M; Li, W; Li, X; Peng, Y; Song, H; Tang, L; Zhang, D; Zhang, Y | 1 |
1 review(s) available for metformin and cholecalciferol
Article | Year |
---|---|
Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer.
Topics: Adaptive Immunity; Animals; Autoimmune Diseases; Autophagy; Benzylisoquinolines; Cholecalciferol; Humans; Immune System Diseases; Immunity, Innate; Indoles; Infections; Isoquinolines; Lysosomes; Maprotiline; Metformin; Neoplasms; Phenols; Pyrroles; Resveratrol; Sirolimus; Spermidine; Stilbenes; Tetrahydroisoquinolines; Trehalose | 2017 |
2 trial(s) available for metformin and cholecalciferol
Article | Year |
---|---|
Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Calcifediol; Calcium; Cholecalciferol; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Insulin, Long-Acting; Male; Metformin; Middle Aged; Young Adult | 2009 |
Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study.
Topics: Administration, Oral; Adult; Biomarkers; Blood Glucose; Case-Control Studies; Cholecalciferol; Diabetes Mellitus, Type 2; Dietary Supplements; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Metformin; Middle Aged; Prospective Studies; Rosiglitazone; Saudi Arabia; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Vitamin D; Young Adult | 2013 |
17 other study(ies) available for metformin and cholecalciferol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling.
Topics: Adaptor Proteins, Signal Transducing; Aspirin; Ataxia Telangiectasia Mutated Proteins; Berberine; Cell Cycle Proteins; Cell Line, Tumor; Cellular Senescence; Cholecalciferol; Deoxyglucose; DNA Damage; DNA-Binding Proteins; Down-Regulation; Enzyme Activation; Flow Cytometry; Histones; Humans; Laser Scanning Cytometry; Membrane Potential, Mitochondrial; Metformin; Mitochondria; Oxidative Stress; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Resveratrol; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins | 2012 |
Effect of vitamin D3 on behavioural and biochemical parameters in diabetes type 1-induced rats.
Topics: Acetylcholinesterase; Animals; Blood Glucose; Body Weight; Cerebral Cortex; Cholecalciferol; Diabetes Mellitus, Type 1; Eating; Fear; Hypoglycemic Agents; Male; Memory; Metformin; Porphobilinogen Synthase; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Streptozocin; Thiobarbituric Acid Reactive Substances; Vitamins | 2014 |
Combined use of vitamin D3 and metformin exhibits synergistic chemopreventive effects on colorectal neoplasia in rats and mice.
Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Blotting, Western; Cholecalciferol; Colorectal Neoplasms; Disease Models, Animal; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Male; Metformin; Mice; Mice, Inbred ICR; Rats; Rats, Wistar; Signal Transduction | 2015 |
Vitamin D₃ prevents the increase in ectonucleotidase activities and ameliorates lipid profile in type 1 diabetic rats.
Topics: 5'-Nucleotidase; Adenosine Deaminase; Adenosine Triphosphatases; Animals; Blood Platelets; Cholecalciferol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Lipid Metabolism; Lipids; Male; Metformin; Phosphoric Diester Hydrolases; Pyrophosphatases; Rats; Rats, Wistar; Streptozocin | 2015 |
Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway.
Topics: AMP-Activated Protein Kinases; Cell Cycle; Cell Line, Tumor; Cholecalciferol; Dose-Response Relationship, Drug; Drug Synergism; Growth Inhibitors; Humans; Male; Metformin; Prostatic Neoplasms; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Synergistic antitumor activity of vitamin D3 combined with metformin in human breast carcinoma MDA-MB-231 cells involves m-TOR related signaling pathways.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Drug Synergism; Female; Humans; Hypoglycemic Agents; Metformin; Signal Transduction; Tetrazolium Salts; Thiazoles; TOR Serine-Threonine Kinases; Vitamins | 2015 |
Vitamin D3 enhances antitumor activity of metformin in human bladder carcinoma SW-780 cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Drug Synergism; Female; Humans; Hypoglycemic Agents; Metformin; Signal Transduction; Tetrazolium Salts; Thiazoles; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms; Vitamins | 2015 |
Metformin alleviates vascular calcification induced by vitamin D3 plus nicotine in rats via the AMPK pathway.
Topics: AMP-Activated Protein Kinases; Animals; Cholecalciferol; Male; Metformin; Nicotine; Rats; Rats, Wistar; Signal Transduction; Vascular Calcification | 2016 |
Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis.
Topics: Adrenal Cortex Hormones; Adult; Cholecalciferol; Coal Tar; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Immunologic Factors; Male; Metformin; Middle Aged; Pioglitazone; Psoriasis; Thiazolidinediones | 2017 |
Vitamin D3 deficiency is associated with more severe insulin resistance and metformin use in patients with type 2 diabetes.
Topics: Adolescent; Adult; Aged; Body Mass Index; C-Peptide; Cholecalciferol; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Ergocalciferols; Female; Glycemic Control; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Middle Aged; Obesity; Vitamin D Deficiency; Young Adult | 2020 |
Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: role of AMPK/SIRT1 activation and DPP-4 inhibition.
Topics: AMP-Activated Protein Kinases; Animals; Cholecalciferol; Dipeptidyl-Peptidase IV Inhibitors; Male; Metabolic Syndrome; Metformin; Rats | 2021 |
Vitamin D3 potentiates the nephroprotective effects of vildagliptin-metformin combination in a rat model of metabolic syndrome.
Topics: Adamantane; Animals; Cholecalciferol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Nitriles; Pyrrolidines; Rats; Rats, Wistar; Vildagliptin | 2022 |
Cholecalciferol and metformin protect against lipopolysaccharide-induced endothelial dysfunction and senescence by modulating sirtuin-1 and protein arginine methyltransferase-1.
Topics: Antioxidants; Arginine; Cell Cycle Checkpoints; Cell Line; Cellular Senescence; Cholecalciferol; Endothelium; Homocysteine; Humans; Lipopolysaccharides; Metformin; Methylation; NAD; Nitric Oxide; Protective Agents; Protein-Arginine N-Methyltransferases; Repressor Proteins; S-Adenosylmethionine; Sirtuin 1; Telomerase; Vitamin D Response Element | 2021 |
Neuromodulatory effect of the combination of metformin and vitamin D
Topics: 5'-Nucleotidase; Adenosine; Animals; Cholecalciferol; Diabetes Mellitus, Type 1; Metformin; Rats | 2023 |
Impact of Vitamin D3 on Carbonyl-Oxidative Stress and Matrix Metalloproteinases after Acute Intracerebral Hemorrhage in Rats with Type 2 Diabetes Mellitus.
Topics: Advanced Oxidation Protein Products; Animals; Biomarkers; Cerebral Hemorrhage; Cholecalciferol; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metformin; Oxidative Stress; Rats; Serum Albumin | 2023 |
Vitamin D3 alleviates lung fibrosis of type 2 diabetic rats via SIRT3 mediated suppression of pyroptosis.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cholecalciferol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Metformin; Pulmonary Fibrosis; Pyroptosis; Rats; Rats, Sprague-Dawley; Sirtuin 3 | 2023 |